|
1) Liu JP, Baker J, Perkins AS, et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf-1r). Cell. 1993; 75: 59-72
|
|
|
|
2) Renehan AG, Zwahlen M, Minder C, et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004; 363: 1346-53
|
|
|
|
|
3) Firth SM, Baxtar RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev. 2002; 23: 824-54
|
|
|
|
|
|
4) McCaig C, Perks CM, Holly JM. Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin. J Cell Sci. 2002; 115: 4293-303
|
|
|
|
|
|
5) Yu H, Spitz MR, Mistry J, et al. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst. 1999; 91: 151-6
|
|
|
|
|
|
6) Lukanova A, Toniolo P, Akhmedkhanov A, et al. A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women. Int J Cancer. 2001; 92: 888-92
|
|
|
|
|
|
7) London SJ, Yuan JM, Travlos GS, et al. Insulin-like growth factor I, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China. J Natl Cancer Inst. 2002; 94: 749-54
|
|
|
|
|
|
8) Spitz MR, Barnett MJ, Goodman GE, et al. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort. Cancer Epidemiol Biomarkers Prev. 2002; 11: 1413-8
|
|
|
|
|
|
9) Kaklamani VG, Linos A, Kaklamani E, et al. Age, sex, and smoking are predictors of circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3. J Clin Oncol. 1999; 17: 813-7
|
|
|
|
|
|
10) Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 1995; 16: 3-34
|
|
|
|
|
|
11) Uh ST, Inoue Y, King TE Jr, et al. Morphometric analysis of insulin-like growth factor-I localization in lung tissues of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998; 158: 1626-35
|
|
|
|
|
|
12) Aston C, Jagirdar J, Lee TC, et al. Enhanced insulin-like growth factor molecules in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1995; 151: 1597-603
|
|
|
|
|
|
13) Homma S, Nagaoka I, Abe H, et al. Localization of platelet-derived growth factor and insulin-like growth factor I in the fibrotic lung. Am J Respir Crit Care Med. 1995; 152: 2084-9
|
|
|
|
|
|
14) Krein PM, Winston BW. Roles for insulin-like growth factor I and transforming growth factor-beta in fibrotic lung disease. Chest. 2002; 122: 289S-93S
|
|
|
|
|
|
15) Frankel SK, Moats-Staats BM, Cool CD, et al. Human insulin-like growth factor-IA expression in transgenic mice promotes adenomatous hyperplasia but not pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2005; 288: L805-12
|
|
|
|
|
|
16) Pilewski JM, Liu L, Henry AC, et al. Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. Am J Pathol. 2005; 166: 399-407
|
|
|
|
|
|
17) Hoshino M, Nakamura Y, Sim J, et al. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol. 1998; 102: 783-8
|
|
|
|
|
|
18) Hoshino M, Nakamura Y, Sim JJ, et al. Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma. Clin Exp Allergy. 1998; 28: 568-77
|
|
|
|
|
|
19) Yamashita N, Tashimo H, Ishida H, et al. Role of insulin-like growth factor-I in allergen-induced airway inflammation and remodeling. Cell Immunol. 2005; 235: 85-91
|
|
|
|
|